Ann: Notice of Extraordinary General Meeting/Proxy Form, page-20

Hi Guys,

have recently purchased SUD and noticed a bit of hate on these forums (from the companies history i can see why). A few things worth noting though if you dont mind me saying. Paul Hopper is a pretty onto it guy, he has a history of getting into small cap biotech companies and pivoting them toward cancer biotech companies. to name a few PTX, IMU, CHM. Please look at their share price the last 12 months (although CHM is a new company so not worth looking at yet). this will be SUD next year, the company you knew has gone and replaced with a new exciting prospect.the IPO of iNKT is really interesting and why I decided to buy in. But from my experience if Paul hopper has got involved its worth watching.

Just my 2 cents.